Author Correction: TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A

Affiliations

• ¹ UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.
• ² The Francis Crick Institute, London, UK.
• ³ National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.
• ⁴ Queen Square Brain Bank, UCL Queen Square Institute of Neurology, University College London, London, UK.
• ⁵ Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.
• ⁶ Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, MD, USA.
• ⁷ Center for Genomics of Neurodegenerative Disease, New York Genome Center (NYGC), New York, NY, USA.
• ⁸ NeuroResource, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, London, UK.
• ⁹ Great Ormond Street Institute of Child Health, Genetics and Genomic Medicine, University College London, London, UK.
• ¹⁰ Medical Scientist Training Program, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
• ¹¹ Molecular Genomics Core, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD, USA.
• ¹² UK Dementia Research Institute, University College London, London, UK.
• ¹³ Nash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ¹⁴ Ronald M. Loeb Center for Alzheimer's Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ¹⁵ Department of Genetics and Genomic Sciences and Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ¹⁶ Estelle and Daniel Maggin Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• ¹⁷ Department of Genetics, Evolution and Environment, UCL Genetics Institute, University College London, London, UK.
• ¹⁸ Department of Molecular Biology and Nanobiotechnology, National Institute of Chemistry, Ljubljana, Slovenia.
• ¹⁹ Molecular Pathology Lab, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
• ²⁰ National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA. [email protected].
• ²¹ UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK. [email protected].